The Converging Roles of microRNAs and Lipid Metabolism in Atherosclerotic Cardiovascular Disease and Cancer

dc.contributor.authorVladimirov, Sandra
dc.contributor.authorTomaševic, Marija
dc.contributor.authorPopov, Nemanja
dc.contributor.authorMunjas, Jelena
dc.contributor.authorDe Gonzalo-Calvo, Davd
dc.contributor.authorSopic, Miron
dc.date.accessioned2025-07-07T12:26:59Z
dc.date.available2025-07-07T12:26:59Z
dc.date.embargoEndDate2026-06-08
dc.date.issued2025
dc.description.abstractCancer and atherosclerotic cardiovascular disease (ASCVD) are the main causes of mortality worldwide. The complex relationship between these two diseases has long puzzled scientists, with lipid metabolism emerging as a promising area for research and therapy of both diseases. Cholesterol accumulation promotes the formation of atherosclerotic plaques, while dysregulated lipid metabolism favours the progression of tumours. MicroRNAs (miRNAs) have been identified as key post-transcriptional regulators of lipid metabolism, influencing cholesterol synthesis and efflux, fatty acid oxidation and lipoprotein function. MiR-33, miR-144 and miR-122 modulate important target proteins such as sterol regulatory element-binding proteins (SREBPs), ATP-binding cassette transporter A1 (ABCA1) and peroxisome proliferator-activated receptor gamma (PPARγ) and thus control metabolic reprogramming in both cancer and ASCVD. In cancer, miRNA-mediated lipid reprogramming promotes proliferation, immune evasion and metastasis, whereas dysregulated miRNAs in ASCVD contribute to foam cell formation, chronic inflammation and vascular dysfunction. The dual role of miRNAs, acting either as tumour suppressors or oncogenes, highlights their complex impact on lipid-related pathophysiology. Moreover, miRNA-based therapeutic strategies, including antagomirs and miRNA mimics, hold promise for targeted intervention in both diseases, which could reduce ASCVD risk in cancer patients and improve long-term outcomes. Understanding the intricate interactions between miRNAs, lipid metabolism and disease progression provides new insights into the overlapping molecular mechanisms of cancer and ASCVD and opens new therapeutic opportunities in the field of cardio-oncology.
dc.description.sponsorshipDdGC has received financial support from Instituto de Salud Carlos III (Miguel Servet 2020: CP20/00041), co-funded by the European Union. SV, MS, MT, NP and JM receive funding through two Grant Agreements with University of Belgrade-Faculty of Pharmacy No 451-03-136/2025-03/ 200161 and No 451-03-137/2025-03/ 200161 and European Union (HORIZON-MSCA-2021-SE-01-01 - MSCA Staff Exchanges 2021 CardioSCOPE 101086397). Additionally, MS receives funding from European Union (HORIZON-MSCA-2021-PF- MAACS
dc.identifier.doihttps://doi.org/10.1016/j.semcancer.2025.06.005
dc.identifier.issn1044-579X
dc.identifier.issn1096-3650
dc.identifier.urihttps://hdl.handle.net/10459.1/468277
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofVersió postprint del document publicat a https://doi.org/10.1016/j.semcancer.2025.06.005
dc.relation.ispartofSeminars in Cancer Biology, 2025, vol. 114, p. 41-59
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/HE/101086397/EU/CardioSCOPE
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/HE/101064175/EU/MAACS
dc.rightscc-by-nc-nd (c) Elsevier, 2025
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCancer
dc.subjectAtherosclerosis
dc.subjectLipid Metabolism
dc.subjectMicroRNA
dc.subjectCholesterol Homeostasis
dc.subjectCardio-Oncology
dc.titleThe Converging Roles of microRNAs and Lipid Metabolism in Atherosclerotic Cardiovascular Disease and Cancer
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/acceptedVersion
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
semcanbio_a2025v114p41.pdf
Size:
1.24 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
639 B
Format:
Item-specific license agreed upon to submission
Description: